Full-Time

Principal Device Engineer

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Hybrid position with 50% remote working and 25% travel expected.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor of Science in engineering or scientific discipline and 10+ years’ experience in combination product or medical device development of complex technical products or advanced degree and 5+ years' experience.
  • Expert in device design from innovation to late-stage development
  • Experience with pumps or infusion systems
  • Experience working with research and clinical development teams, solid understanding of related issues and challenges
  • Experience in third party management (of manufacturers and vendors) is preferred
  • Expertise around regulatory requirements for parenteral combination products is preferred (21 CFR parts 4 & 820, ISO 13485, 14971 & IEC 62366)
  • Strong knowledge of the US/EU external device-mediated drug delivery technology innovation eco-system
  • Solid experience in technology development through external partnership with third parties
  • Strong leadership, communication, and presentation skills
  • Capable of capturing unmet needs and translating them into product requirements
  • International business experience leading multicultural and / or multinational team(s)
  • Play to win mindset
  • Extensive experience with successfully influencing and rapid decision making in matrix and / or governance driven environments
  • Attention to details with meticulous planning
Responsibilities
  • Lead and facilitate device development and technology innovation based on clinical and patient needs, commercial and operational requirements and industry trends, create impactful solutions to expand Sanofi device IP portfolio and strength.
  • Work with new device technology research team to evaluate new device technology and product solutions for early stage program development
  • Lead the development of prototypes and ensure rigorous testing to validate the performance and safety into the final combination products.
  • Conduct required studies and impact assessment by working with internal and external partners and stakeholders to establish technical and commercial feasibility
  • Advance the novel technology and product concepts to be clinical ready and create full development roadmap
  • Embedded into cross-functional program teams serving as the single point of contact of GDPU function for device programs
  • Interface with internal and external device development partners to align resource and priorities to transition and support new device development programs
  • Align with key stakeholders on the selected device solution to meet clinical program needs
  • Generate the integrated development plan and resource need
  • Manage all device related development activities to ensure on-time, on-budget execution
  • Provide support and leadership in due diligence efforts involving novel device technologies

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of new products. The company's goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI tool Muse could reduce clinical trial timelines, boosting R&D efficiency.
  • Dupixent's potential FDA approval for CSU could increase Sanofi's dermatological market share.
  • Sanofi's investment in SureChill supports sustainable vaccine distribution in emerging markets.

What critics are saying

  • High competition in radioligand therapy may affect Sanofi's returns on Orano Med investment.
  • Potential delays in Dupixent's FDA approval for CSU could impact revenue.

What makes Sanofi unique

  • Sanofi's collaboration with OpenAI on Muse enhances AI-driven patient recruitment.
  • Dupixent's EU approval for eosinophilic esophagitis sets a pediatric market precedent.
  • Sanofi's investment in Orano Med advances radioligand therapy innovation.

Help us improve and share your feedback! Did you find this helpful?